# Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects.

> **NCT00147576** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 88 (actual)

## Conditions studied

- Alcoholism

## Interventions

- **DRUG:** CP-866,087

## Key facts

- **NCT ID:** NCT00147576
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2012-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00147576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00147576, "Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects.". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00147576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*